With so much activity around cancer vaccines and immunotherapy right now, can you afford to miss out? It is the place where the global market will come together to share the latest in early-stage scientific advancements, present clinical trial data, discuss new formulations of cancer vaccines and assess the future of combination treatments. Make sure that people are aware of the work you are doing to put yourself at the forefront of the industry.
The Ebola & Zika outbreaks brought emerging and re-emerging diseases screaming into the limelight. This brought with it a renewed vigor for vaccines from the public and a catalyst for the scientific community to progress vaccines for diseases such as Ebola, Malaria, Dengue, and Chikungunya. Use this Conference to meet with and demonstrate your knowledge to the organizations who are pushing forward in this area.
This event will tackle the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. Ensure you use this event to make people aware of your expertise around key topics such as universal and seasonal flu, maternal immunization and pandemic preparedness.
With the animal vaccines market predicted to be worth $8.6 billion by 2018, can you really afford not to be a core service provider for these manufacturers? An increased focus on zoonotic infectious diseases and more attention towards the economic impact of disease in livestock of economic importance, make it clear why veterinary vaccines are coming into the limelight. This event will provide a platform for you to showcase how you are moving veterinary vaccine development methods forward, from technology to regulation and manufacture.
With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale. Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing.
This conference provides a space for those directly involved in cementing the details of partnerships with big pharma, biotechs, academia and non-profit organisations to share their case studies and gain insight into best practice. If you are looking for potential partnerships and collaborations, makes sure you participate in this conference to meet new vaccine biotechs showcasing their technology and pipeline.
As new technologies and personalized vaccines become the norm, the dynamic of clinical trials has to evolve. This focused clinical development conference will allow you to showcase your services to those who are looking to run new trial models, need support in choosing and gaining approval for different clinical endpoints and want to understand how to get the best out of the information collected.
During the “decade of vaccines” the introduction of new vaccines, the vaccination of groups beyond infancy and tackling the equity gap in providing vaccines to all has meant that outdated immunization supply chains have been overstretched and have outgrown their ability to cope. Join us in Washington to listen and learn from key thought leaders in this space, and showcase your solutions to challenges in vaccine storage, distribution, management and stock control to ensure that we achieve future global immunization goals.
With the ever-increasing volume in data and a growing number of new vaccines entering the market it has never been more important to leverage new technologies and methods to improve the efficiency and accuracy of pharmacovigilance for vaccines. This focussed vaccine safety and pharmacovigilance conference will allow you to listen and learn from key thought leaders in this space, as well as to showcase any solutions that are greatly needed in order to revolutionise and replace outdated ways of working. Furthermore, escalating incidences of vaccine-refusal makes the importance of effective communication paramount, so join us to present your most successful strategies